The use of HIV treatment to prevent mother-to-child transmission

Published: 01 June 2012
  • Effective HIV treatment can reduce the risk of mother-to-child transmission dramatically, by lowering maternal viral load, and by reducing the presence of HIV in cervical and vaginal fluids.
  • The transmission rate for babies of women on combination therapy and with a viral load of less than 50 copies/ml is 0.1%.
  • When a pregnant woman should start treatment, and on which regimen, will depend on her particular clinical situation and are covered in BHIVA guidelines.
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.